Evidence map›Paper›PMID 39658675›Full record

ArticleEuropean journal of human genetics : EJHG2024

Correction: Phenotype-driven genomics enhance diagnosis in children with unresolved neuromuscular diseases.

Berta Estévez-Arias, Leslie Matalonga, Delia Yubero, Kiran Polavarapu, Anna Codina, Carlos Ortez, Laura Carrera-García, Jesica Expósito-Escudero, Cristina Jou, Stefanie Meyer and 17 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in European journal of human genetics : EJHG, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors.

Berta Estévez-AriasNeuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain.ORCID http://orcid.org/0000-0002-1711-7489
Leslie MatalongaCentro Nacional de Análisis Genómico (CNAG), Barcelona, Spain.
Delia YuberoCenter for Biomedical Research Network on Rare Diseases (CIBERER), ISCIII, Barcelona, Spain.
Kiran PolavarapuChildren's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.ORCID http://orcid.org/0000-0002-8879-6001
Anna CodinaApplied Research in Neuromuscular Diseases, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
Carlos OrtezNeuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain.
Laura Carrera-GarcíaNeuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain.ORCID http://orcid.org/0000-0003-4762-7591
Jesica Expósito-EscuderoNeuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain.ORCID http://orcid.org/0000-0002-6233-823X
Cristina JouUniversitat de Barcelona (UB), Barcelona, Spain.
Stefanie MeyerChildren's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.
Ozge Aksel KilicarslanChildren's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.
Alberto AlemanChildren's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.ORCID http://orcid.org/0000-0002-8820-693X
Rachel ThompsonChildren's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.
Rebeka LuknárováSchool of Computation, Information and Technology, Technical University of Munich, Munich, Germany.
Anna Esteve-CodinaCentro Nacional de Análisis Genómico (CNAG), Barcelona, Spain.
Marta GutCentro Nacional de Análisis Genómico (CNAG), Barcelona, Spain.
Steven LaurieCentro Nacional de Análisis Genómico (CNAG), Barcelona, Spain.ORCID http://orcid.org/0000-0003-3913-5829
German DemidovInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.ORCID http://orcid.org/0000-0001-9075-4276
Vicente A YépezSchool of Computation, Information and Technology, Technical University of Munich, Munich, Germany.
Sergi BeltranCentro Nacional de Análisis Genómico (CNAG), Barcelona, Spain.
Julien GagneurSchool of Computation, Information and Technology, Technical University of Munich, Munich, Germany.
Ana TopfThe John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.ORCID http://orcid.org/0000-0002-9227-2526
Hanns LochmüllerCentro Nacional de Análisis Genómico (CNAG), Barcelona, Spain.ORCID http://orcid.org/0000-0003-2324-8001
Andres NascimentoNeuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain.
Janet HoenickaLaboratory of Neurogenetics and Molecular Medicine, Center for Genomic Sciences in Medicine, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
Francesc PalauLaboratory of Neurogenetics and Molecular Medicine, Center for Genomic Sciences in Medicine, Institut de Recerca Sant Joan de Déu, Barcelona, Spain. francesc.palau@sjd.es.ORCID http://orcid.org/0000-0002-8635-5421
Daniel Natera-de BenitoNeuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain. daniel.natera@sjd.es.ORCID http://orcid.org/0000-0001-7764-2085

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39658675

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.